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Abstract 
Review on NRIP1, with data on DNA, on the protein 
encoded, and where the gene is implicated. 
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Other names 
FLJ77253, RIP140 
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Location 
21q11.2 
DNA/RNA 
Figure 1:  Schematic representation of FZD4 gene that contains a total of two exons and FZD4 transcript. 
Description 
The gene encompasses approximately 100 Kb and 
may contain up to 7 exons. The entire protein-coding 
region is contained within the last exon. 
Transcription 
Transcription is complex. Alternative spliced 
transcripts containing distinct combinations of 5' 
non-coding exons occur. Alternative promoters have 
been described and are proposed to mediate tissue 
specific expression of NRIP1. NRIP1 is induced by 
a number of hormone nuclear receptors including the 
receptors for estrogen, retinoic acid, androgen, 
progestins, vitamin D3, peroxisome proliferators-
activated receptor-alpha (PPARalpha) and estrogen 
related receptor-alpha (ERRalpha). NRIP1 gene 
transcription is also induced by E2F transcription 
factors.  
NRIP1 mRNA is widely expressed in various tissues 
and cell types. 
Protein 
NRIP1 (nuclear receptor interacting protein 1)  
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Description 
NRIP1 consists of 1158 amino acids. NRIP1 
contains ten LXXLL nuclear receptor interaction 
motifs and four transcriptional repression domains 
(RD 1-4). NRIP1 also contains four c-terminal 
binding protein (CtBP) interaction motifs. NRIP1 
activity is regulated by a variety of posttranslational 
modifications including acetylation, methylation, 
phosphorylation, sumoylation, and pyridoxal-
phosphate (PLP) conjugation. 
 
Expression 
NRIP1 is expressed at low levels in most tissues and 
is induced in response to hormonal signals. NRIP1 is 
highly expressed in metabolic and reproductive 
organs and tissues including the liver, adipose tissue, 
skeletal muscle, ovary and endometrium. 
Localisation 
NRIP1 is mainly expressed in the nucleus and 
contains two putative nuclear localization signals 
(NLS). 
Function 
NRIP1 is a co-repressor of a large number of nuclear 
receptors. NRIP1 interacts preferentially with 
ligand-bound nuclear receptors and inhibits 
transactivation by recruitment of histone 
deacetylases and CtBP. Knockout mice studies 
revealed that NRIP1 has a physiologic role in energy 
homeostasis, muscle metabolism, adipocyte and 
hepatocyte function, mitochondrial activity, 
inflammation, reproduction and cognition. Data 
suggest that these roles are mediated by NRIP1 
repression of nuclear receptor mediated gene 
expression including gene expression mediated by 
the estrogen receptor, liver X receptor, PPARs, 
steroidogenic factor 1 (SF1) and ERR. 
 
NRIP1 has been shown to regulate retinoic acid 
mediated differentiation and growth suppression of 
human embryonal carcinoma cells and the 
proliferation of breast cancer cells in vitro. A 
potential role for NRIP1 in cancer cachexia has been 
suggested. Interestingly, NRIP1 also regulates the 
activity of other transcription factors including E2Fs 
and NFKB. 
 
The fact that NRIP1 expression can be regulated by 
multiple transcription factors and especially nuclear 
receptors and their ligands and that NRIP1 can 
inhibits the activity of multiple nuclear receptors 
implies a potential role in the biology of hormone-
dependent cancers. This role in cancer biology which 
has recently been described in colon, stomach, breast 
and cervix. 
Homology 
NRIP1 is highly conserved throughout vertebrates. 
There is only a single isoform in humans and mice. 
Mutations 
Germinal 
Several synonymous and non-synonymous SNPs 
have been identified. To date no somatic tumor 
mutations have been noted. 
- Arg448Gly has been associated with 
endometriosis. 
- Gly75Gly has been associated with male infertility. 
Implicated in 
Hormone dependent cancers 
In a variety of cancer cell culture systems mouse 
models and tissue arrays, NRIP1 has been shown to 
regulate the activity of a number of nuclear receptors 
involved in hormone-dependent cancers including 
estrogen, retinoid, progesterone and androgen 
receptors. Moreover, NRIP1 mRNA is finely 
regulated during cell cycle progression, modulating 
cell growth and apoptosis. Finally, NRIP1 
overexpression is associated with a significantly 
shorter overall survival of cervical cancer patients 
and discriminates luminal breast cancers. 
Cancer cachexia 
NRIP1 was induced in livers of starved, septic, and 
tumor-bearing mice. Liver-specific knockdown of 
NRIP1 led to increased hepatic TG release and 
alleviated hepatic steatosis in tumor-bearing, 
cachectic animals. NRIP1 was found to control the 
expression of lipid-metabolizing genes in liver. 
Obesity and metabolic disorders 
NRIP1 knockout mice are lean and are resistant to 
high-fat diet induced obesity. NRIP1 regulates genes 
involved in energy homeostasis in metabolic organs. 
Moreover, low level of NRIP1 restores the rates of 
fatty-acids uptake in the basal state, in part via a 
NRIP1 (nuclear receptor interacting protein 1)  
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reduction in upstream insulin signaling. In addition, 
increased NRIP1 level may be closely associated 
with inflammation and disorder of lipid and glucose 
metabolism in diabetic patients. In addition, 
detectable serum NRIP1 protein level changes is 
associated with weight loss in humans. 
Infertility 
NRIP1 knockout mice are infertile due to a defect in 
ovulation. Also the above-mentioned SNPs have 
been proposed to be associated with endometriosis 
and male fertility. 
Gastro-intestinal homeostasis and 
tumorigenesis 
Using molecular and cellular approaches, transgenic 
mouse models and human colorectal biopsies, 
NRIP1 has been shown to inhibit cell proliferation 
and apoptosis in the murine intestinal epithelium. In 
addition, NRIP1 exerts a negative control on 
Wnt/beta-catenin signaling by positively regulating 
the expression of the tumor suppressor gene APC. 
High NRIP1 expression is associated with a 
significantly longer overall survival of colorectal 
cancer patients. Interestingly, whereas NRIP1 
expression tends to decrease in colorectal cancers as 
compared to adjacent normal tissues, an increase of 
its expression was noticed in gastric cancer as 
compared to normal stomach. 
Cognition and neural cells 
The NRIP1 gene depletion in mice results in learning 
and memory deficits as well as stress response, 
bringing to light a major role for this transcriptional 
coregulator in the neurophysiological developmental 
mechanisms underlying cognitive functions. In 
addition, NRIP1 plays a relevant role in Down 
syndrome mitochondrial dysfunction. Moreover, 
NRIP1 expression increases during neural 
differentiation of human embryonic stem cells and is 
negatively correlated with stem cell markers Oct4 
and Sox2 during early stages of neural 
differentiation. 
Aging and longevity 
The deletion of NRIP1 in female mice can 
significantly extend longevity compared to wild-
type females. 
Immunity and inflammation 
Overexpression of NRIP1 in macrophages results in 
M1‑ like polarization and expansion during the 
inflammatory response. Conversely, decreased 
expression of NRIP1 in macrophages reduces the 
number of M1‑ like macrophages and increases the 
number of alternatively polarized cells, which 
collectively promote endotoxin tolerance and relieve 
inflammation. 
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